Anxiety disorder, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients between 18 and 60 years of ag; ASA I and II; who had a unilateral fracture of the zygomatic bone; with a trauma time of less than 15 days; and who showed indication of surgical treatment with at least 2 access points and fixation.
Exclusion criteria
Exclusion criteria: Patients who do not fit the planning of surgical and anesthetic techniques; have fractures in other regions; need coronal access; use other medications in the postoperative period; or present allergy to study medications will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: It is expected to improve the operative pain of patients who use melatonin through the use of transoperative opioids when compared to placebo, from the finding of a variation of at least 5% between groups.;Result Found 1: Patients using melatonin required less opioids compared to placebo (0.296 more or less 0.036 mcg/kg/ min vs. 0.372 more ou less 0.037 mcg/kg /min), with statistical difference from finding a variation of at minus 5% between groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome 2: It is expected to find an improvement in the sleep quality of the inpatients who use melatonin, evaluated using the Sleep Quality Rating Scale.;Result Found 2: In the sleep quality evaluation of the night before surgery, 61.1% of the patients in the Melatonin group reported better or much better sleep than usual, while 100% of the Placebo group reported worse sleep than or equal to usual (p less than 0.001). | — |
Countries
Brazil
Contacts
Universidade de Pernambuco